Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta

British Journal of Pharmacology

Volumn 120, Issue 3, 1997, Pages 476-480

  Löffler, Cornelia ^a   Quast, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

3H P1075; Glibenclamide binding; K(ATP) channel; K(ATP) channel openers; Metabolic dependence of binding; Rat aorta; Sulphonylurea receptor

Indexed keywords

4 [[2 (1 PIPERIDYL)BENZHYDRYL]CARBAMOYLMETHYL]BENZOIC ACID; DRUG RECEPTOR; GLIBENCLAMIDE; GLIBORNURIDE; GLIPIZIDE; POTASSIUM CHANNEL;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING AFFINITY; BINDING SITE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA, THORACIC; BINDING, COMPETITIVE; GLYBURIDE; HYPOGLYCEMIC AGENTS; KINETICS; MALE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; SULFONYLUREA COMPOUNDS;

EID: 0031024433     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700919     Document Type: Article

References (31)

1. +-channels. Cell Signal, 2, 197-214.
2. ASHCROFT, S.J.H. & ASHCROFT, F.M. (1992). The sulfonylurea receptor. Biochim. Biophys. Acta, 1175, 45-59.
3. + channel activation by nucleoside diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br. J. Pharmacol., 110, 573-582.
4. BEVINGTON, P.R. (1969). Data Reduction and Error Analysis for the Physical Sciences, pp. 55-65 and 92-118. New York: McGraw-Hill.
5. + efflux-stimulating and vasorelaxant properties of cromakalim. Eur. J. Pharmacol., 200, 163-165.
6. + channel openers in rat aorta. J. Biol. Chem., 267, 11689-11690.
7. + channels. Ann. Rev. Pharmacol. Toxicol., 33, 597-637.
8. EDWARDS, G. & WESTON, A.H. (1994). Effect of potassium channel modulating drugs on isolated smooth muscle. In Handbook of Experimental Pharmacology, Vol. 111, ed Szekeres, L.J. & Papp, G. pp. 469-531. Heidelberg: Springer.
9. GARRINO, M.G. & HENQUIN, J.C. (1988). Highly potent and stereo-selective effects of the benzoic acid derivative AZ-DF 265 on pancreatic β-cells. Br. J. Pharmacol., 93, 61-68.
10. 3H]glyburide, to neuronal and muscle preparations. J. Pharmacol. Exp. Ther., 257, 1162-1171.
11. HALL, S.M. & HAWORTH, S.G. (1996). Effect of cold preservation on pulmonary arterial smooth muscle cells. Am. J. Physiol., 270, L435-L445.
12. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science, 270, 1166-1170.
13. + channels. Neuron, 16, 1011-1017.
14. + channels from aortic smooth muscle incorporated into planar lipid bilayers. Am. J. Physiol., 261, H604-H609.
15. MANLEY, P.W., QUAST, U., ANDRES, H. & BRAY, K. (1993). Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers. J. Med. Chem., 36, 2004-2010.
16. + channel (ROMK2) to the inhibitory sulfonylurea compound, glibenclamide, is enhanced by co-expression with the ATP-binding cassette transporter CFTR. Proc. Natl. Acad. Sci. U.S.A., 93, 8083-8088.
17. NIKI, I. & ASHCROFT, S.J.H. (1991). Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic β-cell line, HIT T15. Biochim. Biophys. Acta, 1133, 95-101.
18. PANTEN, U., BURGFELD, J., GOERKE, F., RENNIKE, M., SCHWANSTECHER, M., WALLASCH, A., ZÜNKLER, B.J. & LENZEN, S. (1989). Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol., 38, 1217-1229.
19. QUAST, U. (1992). Potassium channel openers: pharmacological and clinical aspects. Fundam. Clin. Pharmacol., 6, 279-293.
20. QUAST U. (1996). Effects of potassium channel activators in isolated blood vessels. In Potassium Channels and their Modulators: From Synthesis to Clinical Experience. ed. Evans, J.M., Hamilton, T.C., Longman, S.D. & Stemp, G. pp. 173-195. London: Taylor & Francis.
21. 3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Mol. Pharmacol., 43, 474-481.
22. - channel. Pflügers Arch., 429, 659-662.
23. SAKURA, H., ÄMMÄLÄ, C., SMITH, P.A., GRIBBLE, F.M. & ASHCROFT, F.M. (1995). Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett., 377, 338-344.
24. ++-complex of ATP. J. Pharmacol. Exp. Ther., 262, 495-502.
25. 2+ complex of ATP. J. Neurochem., 59, 1325-1335.
26. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J. Gen. Physiol., 100, 573-591.
27. TALLARIDA, R.J. (1995). Receptor discrimination and control of agonist-antagonist binding. Am. J. Physiol., 269, E379-E391.
28. WANG, W., CASSOLA, A. & GIEBISCH, G. (1994). Involvement of actin cytoskeleton in modulation of apical K channel activity in rat collecting duct. Am. J. Physiol., 267, F592-F598.
29. + current in canine coronary smooth muscle cells. Pflügers Arch., 427, 110-120.
30. ZINI, S., BEN-ARI, Y. & ASHFORD, M.L.J. (1991). Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine. J. Pharmacol. Exp. Ther., 259, 566-573.
31. ZÜNKLER, B.J., TRUBE, G. & PANTEN, U. (1989). How do sulfonylureas approach their receptor in the B-cell plasma membrane? Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 328-332.